Accidents vasculaires cérébraux
Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 10, Octobre 2009
Accidents vasculaires cérébraux
Page(s) 843 - 846
Section M/S revues : Accidents vasculaires cérébraux (2)
DOI https://doi.org/10.1051/medsci/20092510843
Publié en ligne 15 octobre 2009
  1. Del Zoppo GJ, Levy DE, Wasiewski WW, et al. Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke 2009; 40 : 1687–91.
  2. Kang DW, Yoo SH, Chun S, et al. Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Stroke 2009; 40 : 1653–8.
  3. Di Napoli M, Singh P. Is plasma fibrinogen useful in evaluating ischemic stroke patients ? Why, how, and when. Stroke 2009; 40 : 1549–52.
  4. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 2009; 40 : e380–9.
  5. Whiteley W, Tseng MC, Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke 2008; 39 : 2902–9.
  6. Jauch EC, Lindsell C, Broderick J, et al. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006; 37 : 2508–13.
  7. Dassan P, Keir G, Brown MM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis 2009; 27 : 295–302.
  8. Lynch JR, Blessing R, White WD, et al. Novel diagnostic test for acute stroke. Stroke 2004; 35 : 57–63.
  9. Reynolds MA, Kirchick HJ, Dahlen JR, et al. Early biomarkers of stroke. Clin Chem 2003; 49 : 1733–9.
  10. Laskowitz DT, Kasner SE, Saver J, et al. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the biomarker rapid assessment in ischemic injury (BRAIN) study. Stroke 2009; 40 : 77–85.
  11. Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004; 11 : 156–64.
  12. Doeuvre L, Anglés-Cano E. Cell-derived microparticles unveil their fibrinolytic and proteolytic function. Med Sci (Paris) 2009; 25 : 37–44.
  13. Leroyer AS, Isobe H, Leseche G, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007; 49 : 772–7.
  14. Simak J, Gelderman MP, Yu H, et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006; 4 : 1296–302.
  15. Cherian P, Hankey GJ, Eikelboom JW, et al. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 2003; 34 : 2132–7.
  16. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation ? Arterioscler Thromb Vasc Biol 2006; 26 : 2594–604.
  17. Doeuvre L, Plawinski L, Toti F, Anglés-Cano E. Cell-derived microparticles: a new challenge in neuroscience. J Neurochem 2009; 110 : 457–68.
  18. Horstman LL, Jy W, Minagar A, et al. Cell-derived microparticles and exosomes in neuroinflammatory disorders. Int Rev Neurobiol 2007; 79 : 227–68.
  19. Namba M, Tanaka A, Shimada K, et al. Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood. Arterioscler Thromb Vasc Biol 2007; 27 : 255–6.
  20. Lacroix R, Sabatier F, Mialhe A, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 2007; 110 : 2432–9.
  21. Canault M, Leroyer AS, Peiretti F, et al. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am J Pathol 2007; 171 : 1713–23.
  22. Morel N, Morel O, Petit L, et al. Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury. J Trauma 2008; 64 : 698–704.
  23. Huang M, Hu YY, Dong XQ. High concentrations of procoagulant microparticles in the cerebrospinal fluid and peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. Surg Neurol 2009.
  24. Marzesco AM, Janich P, Wilsch-Brauninger M, et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 2005; 118 : 2849–58.
  25. Scolding NJ, Morgan BP, Houston WA, et al. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 1989; 339 : 620–2.
  26. Wisztorski M, Lemaire R, Stauber J, et al. MALDI imaging: a new technology to discover and validate new biomarkers. Med Sci (Paris) 2007; 23 Spec No 1: 31–6.
  27. Miguet L, Sanglier S, Schaeffer C, et al. Microparticles: a new tool for plasma membrane sub-cellular proteomic. Subcell Biochem 2007; 43 : 21–34.
  28. Zappaterra MD, Lisgo SN, Lindsay S, et al. A comparative proteomic analysis of human and rat embryonic cerebrospinal fluid. J Proteome Res 2007; 6 : 3537–48.
  29. Anglés-Cano E, Balaton A, Le Bonniec B, et al. Production of monoclonal antibodies to the high fibrin-affinity, tissue-type plasminogen activator of human plasma. Demonstration of its endothelial origin by immunolocalization. Blood 1985; 66 : 913–20.
  30. Dignat-George F, Sabatier F, Camoin-Jau L, Sampol J. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2 : 1844–5.
  31. Hugel B, Zobairi F, Freyssinet JM. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2 : 846–7.
  32. Lawrie AS, Albanyan A, Cardigan RA, et al. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 2009; 96 : 206–12.
  33. Bordet R, Ouk T, Onteniente B, et al. Ischémie cérébrale : les pistes thérapeutiques de demain. Med Sci (Paris) 2009; 25 : 847–54.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.